Comparing Second-Line Therapies for Recurrent Mesothelioma
University of Pennsylvania researchers have some hopeful news for people with recurrent mesothelioma after chemotherapy: Second-line immunotherapy might increase their…
-
-
Occupational Asbestos Exposure: The Need for Standardized Assessment
A new report shows how important it is to have a standardized way to assess occupational asbestos exposure in people… -
One in Three Mesothelioma Deaths Go Unreported in Brazil
Brazil has a history of underreporting mesothelioma deaths and the trend is not improving. That is the word from Brazilian… -
New PD-L1 Inhibitor Could Make Mesothelioma Immunotherapy Safer
A new PD-L1 inhibitor may be on the horizon for people with malignant mesothelioma. A Phase I trial suggests it… -
How Long Does Mesothelioma Risk Last After Asbestos Exposure?
If you experienced asbestos exposure more than 30 years ago and you have not developed mesothelioma, your risk for the… -
Personalized Exercise Program Improves Mesothelioma Quality of Life
A new case study suggests that a personalized exercise program could improve the quality of life for people fighting malignant… -
CAR-T Cells + Keytruda: New Immunotherapy for Pleural Mesothelioma?
Researchers at a top US cancer center are experimenting with a new approach to immunotherapy for pleural mesothelioma – with… -
Mesothelioma Update: Drinking and Cancer Risk
A new study on the link between drinking and cancer risk may make people at risk for mesothelioma think twice… -
New Studies | Prognosis | Research | Surgery | Treatments
New Test May Help Doctors Choose the Best Mesothelioma Surgery
A new predictive model may make it easier for cancer doctors to choose the best mesothelioma surgery for each pleural… -
Annual Report on Cancer Death Rates: Good and Bad News for Mesothelioma Patients
The latest report on cancer death rates in the US is both good and bad news for people with malignant…
